Hims & Hers CLO Files SEC Form 4 Filing Showing Share Sale
Soleil Boughton, Chief Legal Officer of Hims & Hers Health (ticker: HIMS), filed a non-discretionary sale of 21,500 shares on August 14. The transaction was part of a pre-arranged tax withholding process tied to the vesting of restricted stock units and did not reflect any change in her assessment of the company's future or valuation. Boughton retained ownership of approximately 339,075 shares post-sale with an estimated value of $9.5 million at that time. The sale occurred amid a challenging market environment for HIMS, which had seen its stock price fall by about 40% over the previous year and was facing legal challenges from the FTC regarding data sharing practices. Despite ongoing litigation concerns, Hims & Hers reported strong quarterly revenue growth of 38%, reaching $753.2 million in Q2, with full-year guidance raised to between $3.1 billion and $3.3 billion.
Tickers: $HIMS
Topics: Hims & Hers insider trading SEC filing